Quantinuum (NASDAQ:QNT) Trading Down 6.1% – Should You Sell?

Quantinuum Inc. (NASDAQ:QNT) shares dropped 6.1% during trading on Thursday . The stock traded as low as $66.77 and last traded at $67.35. 1,094,852 shares changed hands during trading, a decline of 59% from the average daily volume of 2,668,238 shares. The stock had previously closed at $71.74.

Key Stories Impacting Quantinuum

Here are the key news stories impacting Quantinuum this week:

• Positive Sentiment: Oracle partnership expands commercial reach: Quantinuum will deploy its 98-qubit Helios system in a U.S.-based Oracle Cloud Infrastructure data center. The arrangement will let enterprise, academic and research customers access hybrid quantum-AI and high-performance-computing workloads through Oracle’s cloud without owning specialized hardware. Oracle, Quantinuum partner to bring quantum computing to cloud
• Positive Sentiment: Revenue and bookings showed momentum: Second-quarter revenue rose 279% year over year to $8 million, while analysts highlighted strong bookings and improving commercial adoption. Quantinuum also raised its fiscal 2026 revenue outlook to $28 million-$32 million, above the $26.6 million consensus estimate. Quantinuum Reports Second Quarter 2026 Results
• Positive Sentiment: Analysts remain bullish: Rosenblatt reaffirmed a Buy rating with a $155 price target, while Needham maintained Buy at $100 and Cantor Fitzgerald reiterated Overweight with a $90 target. These targets imply substantial potential upside from recent trading levels. Analyst rating updates
• Neutral Sentiment: Technology milestones support the long-term story: Quantinuum said Helios demonstrated near five-nines logical fidelity, strengthening its positioning in fault-tolerant quantum computing. The company also announced a supply-chain collaboration with a major global electronics manufacturer. Quantinuum second-quarter results
• Negative Sentiment: Profitability remains a concern: Quantinuum reported an adjusted loss of $0.28 per share, missing the $0.26 consensus estimate. The loss widened even as revenue grew, and analysts expect the company to remain unprofitable for fiscal 2026. This may be prompting profit-taking after the initial post-earnings enthusiasm. Quantinuum Q2 2026 earnings

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on QNT shares. Morgan Stanley assumed coverage on shares of Quantinuum in a research report on Monday, June 29th. They set an “equal weight” rating and a $78.00 price target on the stock. Jefferies Financial Group set a $85.00 price target on Quantinuum in a research note on Wednesday. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $90.00 price target on shares of Quantinuum in a research report on Wednesday. JPMorgan Chase & Co. started coverage on Quantinuum in a report on Monday, June 29th. They issued an “overweight” rating and a $97.00 price objective for the company. Finally, Zacks Research upgraded shares of Quantinuum to a “hold” rating in a report on Tuesday, June 30th. Ten research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $98.42.

Quantinuum Price Performance

The stock has a 50-day moving average of $62.89.

Quantinuum (NASDAQ:QNT) last released its quarterly earnings data on Tuesday, August 11th. The company reported ($0.28) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.26) by ($0.02). The firm had revenue of $8.00 million during the quarter. As a group, equities research analysts anticipate that Quantinuum Inc. will post -1.61 earnings per share for the current fiscal year.

Insider Activity

In related news, insider Kevin Scott Dehoff bought 15,000 shares of the business’s stock in a transaction dated Friday, June 5th. The stock was bought at an average price of $60.00 per share, for a total transaction of $900,000.00. Following the purchase, the insider owned 126,460 shares in the company, valued at $7,587,600. This represents a 13.46% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Joseph Jimenez purchased 66,665 shares of the firm’s stock in a transaction that occurred on Friday, June 5th. The stock was bought at an average price of $60.00 per share, for a total transaction of $3,999,900.00. Following the purchase, the director owned 72,498 shares in the company, valued at $4,349,880. The trade was a 1,142.89% increase in their position. The SEC filing for this purchase provides additional information. Over the last 90 days, insiders purchased 411,032 shares of company stock valued at $24,661,920.

Institutional Investors Weigh In On Quantinuum

An institutional investor recently bought a new stake in Quantinuum stock. Lisanti Capital Growth LLC bought a new position in shares of Quantinuum Inc. (NASDAQ:QNT) during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 5,005 shares of the company’s stock, valued at approximately $409,000.

Quantinuum Company Profile

Quantinuum is a quantum computing company focused on developing hardware and software for commercial and scientific applications. The company provides access to its quantum systems, along with software tools and services designed to help customers explore use cases in areas such as optimization, materials science, chemistry, cybersecurity, and machine learning.

The company was formed through the combination of Honeywell Quantum Solutions and Cambridge Quantum in 2021. Quantinuum operates internationally and serves a range of customers across enterprise, government, and research markets.